Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(35 sites)
United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -, Orlando, Florida Florida Cancer Specialists - Sarasota, Sarasota, Florida Henry Ford Health System, Detroit, Michigan David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center, Long Island City, New York The Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio Sarah Cannon and HCA Research Institute, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio, Texas New Experimental Therapeutics of Virginia - NEXT Oncology, Fairfax, Virginia France
Institut Paoli-Calmettes, Marseille, Bouches-du-Rhône Institut de Cancerologie de l'Ouest - site St-Herblain, Saint-Herblain, Loire-Atlantique CHU Bordeaux - Hopital Saint-Andre, Bordeaux, Nouvelle-Aquitane IUCT-Oncopole, Toulouse, Occitaine CHU de Nantes - Hopital Nord Laennec, Nantes, Pays de la Loire Region Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome, Lazio Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples South Korea
National Cancer Center, Goyang-si, Gyeonggi-do Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do Severance Hospital, Yonsei University Health System, Seoul Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul Spain
Hospital Universitari Quiron Dexeus Barcelona, Barcelona, Catalonia Hospital Universitario Vall d'Hebron, Barcelona, Catalonia New Experimental Therapeutics (NEXT) Oncology Barcelona, Barcelona South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona Hospital Universitario Ramon y Cajal, Madrid South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC, Madrid New Experimental Therapeutics (NEXT) Oncology Madrid - Hospital Quironsalud Madrid, Madrid South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid Hospital Quirónsalud Málaga, Málaga Clinica Universidad de Navarra - Pamplona, Pamplona Taiwan
Chi-Mei Hospital - Liouying Branch, Liuying, Tainan City National Taiwan University Hospital, Taipei, Taipei City Taichung Veterans General Hospital, Taichung Taipei Veterans General Hospital, Taipei